SelectQuote, Inc. revenue by segment SLQT

SelectQuote, Inc. splits its revenue into 2 lines in its filings. The largest line in Q1 of fiscal 2027, the quarter ended Sep 30, 2026 was Pharmacy at $184.0 million, 66% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q1 FY2027
Sep 30, 2026
Q4 FY2026
Jun 30, 2026
Q3 FY2026
Mar 31, 2026
Q2 FY2026
Dec 31, 2025
Q1 FY2026
Sep 30, 2025
Q4 FY2025
Jun 30, 2025
Q3 FY2025
Mar 31, 2025
Q2 FY2025
Dec 31, 2024
Revenue
1,570
280
322
431
537
329
345
408
481
Pharmacy
796
+0.2%
share 50.7%
184
-15.8%
share 65.7%
190
-9.9%
share 59.0%
195
+5.4%
share 45.3%
227
+26.2%
share 42.3%
219
share 66.5%
211
share 61.0%
185
share 45.4%
180
share 37.4%
Services
773
+0.6%
share 49.3%
96
-13.0%
share 34.3%
132
-2.0%
share 41.0%
236
+5.7%
share 54.7%
310
+2.9%
share 57.7%
110
share 33.5%
135
share 39.0%
223
share 54.6%
301
share 62.6%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Insurance Agents, Brokers & Service (SIC 6411)
Listed as
SLQT (NYSE)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Overland Park, KS
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1794783

Other Insurance Agents, Brokers & Service companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.